EA201790428A1 - Синтез энт-прогестерона и его промежуточных соединений - Google Patents

Синтез энт-прогестерона и его промежуточных соединений

Info

Publication number
EA201790428A1
EA201790428A1 EA201790428A EA201790428A EA201790428A1 EA 201790428 A1 EA201790428 A1 EA 201790428A1 EA 201790428 A EA201790428 A EA 201790428A EA 201790428 A EA201790428 A EA 201790428A EA 201790428 A1 EA201790428 A1 EA 201790428A1
Authority
EA
Eurasian Patent Office
Prior art keywords
progesterone
ent
synthesis
intermediate compounds
compounds
Prior art date
Application number
EA201790428A
Other languages
English (en)
Inventor
Дэниэл Э. Леви
Джон В. Крэн
Original Assignee
Превакус, Инк.
Зе Флорида Стейт Юниверсити Ресерч Фаундейшн, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Превакус, Инк., Зе Флорида Стейт Юниверсити Ресерч Фаундейшн, Инк. filed Critical Превакус, Инк.
Publication of EA201790428A1 publication Critical patent/EA201790428A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J61/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/0805—Compounds with Si-C or Si-Si linkages comprising only Si, C or H atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/50—Organo-phosphines
    • C07F9/5022—Aromatic phosphines (P-C aromatic linkage)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C07F9/65517—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C07J15/005—Retrosteroids (9 beta 10 alfa)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C07J75/005—Preparation of steroids by cyclization of non-steroid compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Настоящее изобретение относится к синтезу энт-прогестерона и его промежуточных соединений.
EA201790428A 2014-09-17 2015-09-17 Синтез энт-прогестерона и его промежуточных соединений EA201790428A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462051900P 2014-09-17 2014-09-17
PCT/US2015/050631 WO2016044558A1 (en) 2014-09-17 2015-09-17 Synthesis of ent-progesterone and intermediates thereof

Publications (1)

Publication Number Publication Date
EA201790428A1 true EA201790428A1 (ru) 2017-08-31

Family

ID=55533837

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201790428A EA201790428A1 (ru) 2014-09-17 2015-09-17 Синтез энт-прогестерона и его промежуточных соединений

Country Status (20)

Country Link
US (1) US20160108081A1 (ru)
EP (1) EP3194418B1 (ru)
JP (1) JP2017535596A (ru)
CN (1) CN108064228A (ru)
AR (1) AR101951A1 (ru)
AU (1) AU2015317651A1 (ru)
BR (1) BR112017005167A2 (ru)
CA (1) CA2961628A1 (ru)
CL (1) CL2017000645A1 (ru)
EA (1) EA201790428A1 (ru)
ES (1) ES2910225T3 (ru)
IL (1) IL251237A0 (ru)
MA (1) MA39411A (ru)
PH (1) PH12017500499A1 (ru)
SG (1) SG11201702115SA (ru)
TN (1) TN2017000088A1 (ru)
TW (1) TW201619183A (ru)
UY (1) UY36306A (ru)
WO (1) WO2016044558A1 (ru)
ZA (1) ZA201701976B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014233156A1 (en) * 2013-03-15 2015-10-15 Prevacus, Inc. Synthesis of ent-progesterone and intermediates thereof
IT201700004904A1 (it) * 2017-01-18 2018-07-18 Ind Chimica Srl PROCESSO PER LA PREPARAZIONE DI 9β,10α-PROGESTERONE (RETROPROGESTERONE)
GB202203328D0 (en) 2022-03-10 2022-04-27 Givaudan Sa Organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2623071A (en) * 1948-05-13 1952-12-23 Synor Res Lab Inc Preparation of substituted cyclopentenones
JPS4926214A (ru) * 1971-07-14 1974-03-08
US4189431A (en) * 1975-08-04 1980-02-19 The Board of Trustees of Leland Stanford Junior University Alkinyl terminating groups in biogenetic-like cyclizations to steroids
JP2001247562A (ja) * 2000-03-07 2001-09-11 Daicel Chem Ind Ltd アミド化合物及びその製造方法
CA2955684A1 (en) * 2008-02-26 2009-09-03 Emory University Steroid analogues for neuroprotection
WO2010088409A2 (en) * 2009-01-30 2010-08-05 Emory University Methods of neuroprotection using neuroprotective steroids and a vitamin d
PT2651915T (pt) * 2010-12-17 2016-07-14 Mitsubishi Tanabe Pharma Corp Composto aricíclico contínuo
AU2014233156A1 (en) * 2013-03-15 2015-10-15 Prevacus, Inc. Synthesis of ent-progesterone and intermediates thereof

Also Published As

Publication number Publication date
IL251237A0 (en) 2017-05-29
US20160108081A1 (en) 2016-04-21
ZA201701976B (en) 2019-06-26
PH12017500499A1 (en) 2017-08-30
SG11201702115SA (en) 2017-04-27
UY36306A (es) 2016-04-29
AU2015317651A1 (en) 2017-04-06
EP3194418B1 (en) 2021-12-15
EP3194418A4 (en) 2018-12-12
EP3194418A1 (en) 2017-07-26
CA2961628A1 (en) 2016-03-24
BR112017005167A2 (pt) 2018-06-19
WO2016044558A1 (en) 2016-03-24
MA39411A (fr) 2016-03-24
ES2910225T3 (es) 2022-05-12
TN2017000088A1 (en) 2018-07-04
CN108064228A (zh) 2018-05-22
CL2017000645A1 (es) 2018-09-14
JP2017535596A (ja) 2017-11-30
AR101951A1 (es) 2017-01-25
TW201619183A (zh) 2016-06-01

Similar Documents

Publication Publication Date Title
ECSP17029371A (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
EA201890093A1 (ru) Комбинированная терапия гемобластозов антителами к cd38 и ингибиторами сурвивина
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
TR201906366T4 (tr) Polisiklik-karbamoilpiridon bileşiklerinin sentezi.
EA202092435A3 (ru) Моноклональные антитела против bcma
MD3827845T2 (ro) Formulări subcutanate de anticorpi anti-CD38 și utilizări ale acestora
EA201691974A1 (ru) Антитела против ox40 и способы их применения
EA201790984A1 (ru) Анти-cd79b антитела и способы их применения
EA202092609A1 (ru) Антитела к cd38 для лечения острого миелолейкоза
MX2017008442A (es) Uso de picolinamidas como fungicidas.
EA201892430A1 (ru) Синтез индазолов
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
EA201691541A1 (ru) Новые анти-baff антитела
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
IN2015CH01182A (ru)
TW201613934A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
BR112016027455A2 (pt) moduladores ppar
EA201691632A1 (ru) Пиразины в качестве модуляторов gpr6
PH12016501201A1 (en) Synthesis of ent-progesterone and intermediates thereof
PH12017500499A1 (en) Synthesis of ent-progesterone and intermediates thereof
EA201692569A1 (ru) Полимиксины с низкой степенью замещения и композиции, их содержащие
EA201691203A1 (ru) Твёрдые формы тенофовира
MX2015012902A (es) Sintesis de ent-progesterona e intermediarios de la misma.
MX2022010854A (es) Peptidos toxicos activados artificialmente.